| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |